| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |